SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US OTC > Medical - Drugs > Elite Pharmaceuticals (ELTP)

Elite's Multi-Billion Dollar Platform:

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
NASDAQ2020 Member Profile
Member Level 
Followed By 74
Posts 13,762
Boards Moderated 2
Alias Born 08/29/12
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/22/2017 5:11:01 PM
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 5/10/2017 5:24:00 PM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 5/10/2017 5:04:05 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/3/2017 6:19:02 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/2/2017 10:51:44 AM
Amended Current Report Filing (8-k/a) "Edgar (US Regulatory)" - 5/1/2017 6:16:17 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/28/2017 5:31:14 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/27/2017 6:48:03 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/27/2017 6:42:25 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/27/2017 6:27:37 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/27/2017 6:19:06 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/27/2017 6:10:49 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/9/2017 4:46:25 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 2/9/2017 4:35:32 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 2/9/2017 4:34:39 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/22/2016 5:25:52 PM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 12/22/2016 5:17:13 PM
Amended Annual Report (10-k/a) "Edgar (US Regulatory)" - 11/17/2016 4:05:38 PM
Amended Quarterly Report (10-q/a) "Edgar (US Regulatory)" - 11/17/2016 4:03:30 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 11/9/2016 5:10:17 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/9/2016 4:42:48 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/1/2016 4:32:35 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/31/2016 4:19:33 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/19/2016 5:48:03 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/9/2016 5:30:55 PM
NASDAQ2020 Member Level  Friday, 05/19/17 09:25:55 PM
Re: dr_lowenstein post# 257089
Post # of 258638 
Elite's Multi-Billion Dollar Platform:
Elite's Current Marketed Products and Pipeline is growing rapidly ! Fully developed its worth Billion$
Start watching for the undisclosed drug filings.
$$$$$$$$$$$$
Elite working on 7 AD opiods concurrently

$Generic Products$$

Commercial Product
Branded Product Equivalent
Therapeutic Category u

1. Hydromorphone Hydrochloride
8 mg Tablets
Dilaudid®
Pain

2. Naltrexone Hydrochloride
50 mg Tablets
Revia®
Opioid Antagonist

3. Phentermine HCl
37.5 mg Tablets
Adipex-P®
Bariatric

4. Phentermine HCI
15 mg and 30 mg Capsules
Adipex-P®
Bariatric

5. Phendimetrazine Tartrate
35 mg Tablets, USP
Bontril®
Bariatric

6. Isradipine
2.5 mg and 5 mg Capsules
N/A
Cardiovascular

7. Hydroxyzine HCI
10 mg, 25 mg, 50 mg Tablets
Atarax®, Vistaril®
Antihistamine

8. Dantrolene Sodium
25 mg, 50 mg and 100 mg Capsules *
Dantrium®
Skeletal Muscle Relaxant

9. Loxapine
5 mg, 10 mg, 25 mg, 50 mg Capsules *
N/A
Antipsychotic

10. Additional Approved ANDA's *
Undisclosed
Undisclosed
* pending manufacturing site transfer


$BRANDED PRODUCTS$$
Commercial Product
Therapeutic Category
Partner

11. Lodrane D®
OTC Allergy
Valeant Pharmaceuticals International, Inc.


$CONTRACT MANUFACTURING$$
Commercial Product
Branded Product Equivalent
Therapeutic Category
Partner

12. Methadone Hydrochloride
10 mg Tablets
Dolophine®
Pain
Ascend Laboratories, LLC


$GENERIC PIPELINE$$

Programs Under Development
Branded Product Equivalent
Therapeutic Category
Development Stage

13. ELI-300 Opioid
Undisclosed
Pain
Early Development

14. ELI-301 Opioid
Undisclosed
Pain
Early Development

15. Oxycodone HCl and Acetaminophen, USP 325 mg
5 mg, 7.5 mg, 10 mg Tablets
Percocet
Pain
Pending FDA Approval

16. Hydrocodone bitartrate and Acetaminophine tablets, 2.5mg/325mg, 5mg/325mg, 7.5mg/325mg and 10mg/325mg tablets
Norco
Pain
Pending FDA Approval


17. Undisclosed Generic
Undisclosed
Undisclosed
Pending FDA Approval

18. Elite/SunGen Generic #1
Undisclosed
CNS Stimulant
In Development

19. Elite/SunGen Generic #2
Undisclosed
CNS Stimulant
In Development

20. Elite/SunGen Generic #3
Undisclosed
Beta-Blocker
In Development

21. Elite/SunGen Generic #4
Undisclosed
Beta-Blocker
In Development

22. Generic Troxyca
Pain

23. Generic Embeda
Pain

24. Generic OxyContin

25. Generic Opana Oxymorphone
Pain


$BRANDED PIPELINE$$

Development Stage
Partner

26. SequestOx™ (ELI-200) Opioid
Pain
NDA Submitted
PDUFA date: July 14, 2016
Epic Pharma LLC

27. ELI-201 ER Opioid
Troxyca equivalent
Pain
Pivotal Bio-equivalence

28. ELI-202 Opioid
Pain
Pivotal Bio-equivalence

29. ELI-216 Opioid ER 24hr (once/day)
Pain
Process Development

30. ELI-400 Opioid
Pain
Process Development

31., ELI-500 Opioid
Pain
Process Development

32. ELI-501 Opioid
Pain
Early Development

33. ELI-600 Opioid
Pain
Process development ELTP
ELTP




You Can Tell A Man's Character By The Way He Treats Those Who Can Do Nothing For Him
SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist